Market Tracker

07/22 5:16pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.24
Delayed Data
As of Jul 22
 -0.11 / -1.18%
Today’s Change
6.96
Today|||52-Week Range
25.25
-46.68%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close9.35
Today’s open9.35
Day’s range9.15 - 9.40
Volume1,108,950
Average volume (3 months)1,561,923
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+55.36%
Earnings growth (this year)-310.38%
Earnings growth (next 5 years)--
Revenue growth (last year)+79.28%
P/E ratioNM
Price/Sales16.26
Price/Book27.87

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...+0.77+1.65%
AXONAxovant Sciences Ltd+0.85+6.39%
MCRBSeres Therapeutics I...+0.81+2.41%
CHRSCoherus BioSciences ...+0.24+1.00%
Data as of 4:00pm ET, 07/22/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$135.1M
Annual profit (last year)-$32.2M
Net profit margin-23.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts